Effect of rosiglitazone on myocardial ischemia-reperfusion injury in rat heart

Korean Journal of Physiology and Pharmacology

Volumn 10, Issue 4, 2006, Pages 181-186

  Ha, Ki Chan ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

Catalase; Ischemia reperfusion; Lipid peroxidation; Peroxisome proliferator activated receptor gamma; Rosiglitazone; Superoxide dismutase

Indexed keywords

CATALASE; GLUTATHIONE; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; ROSIGLITAZONE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; HEART FUNCTION; HEART HEMODYNAMICS; HEART MUSCLE ISCHEMIA; HEART PERFORMANCE; HEART PROTECTION; IN VITRO STUDY; ISOLATED HEART; LIPID PEROXIDATION; MALE; METABOLIC INHIBITION; NONHUMAN; OXIDATIVE STRESS; PROTEIN CONTENT; PROTEIN LOCALIZATION; RAT; REPERFUSION INJURY; TISSUE DISTRIBUTION;

EID: 33748603779     PISSN: 12264512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ambrosio G, Flaherty JT, Duilio C, Tritto I, Santoro G, Elia PP, Condorelli M, Chiariello M. Oxygen radicals generated at reflow induce peroxidation of membrane lipids in reperfused hearts. J Clin Invest 87: 2056-2066, 1991
2. Asimakis GK, Inners-McBride K, Medellin G, Conti VR. Ischemic preconditioning attenuates acidosis and postischemic dysfunction in isolated rat heart. Am J Physiol 263: H887-H894, 1992
3. Beers RF Jr, Sizer IW. A spectrophotometric method for measuring the breakdown of hydrogen peroxide be catalase. J Biol Chem 195: 133-140, 1952
4. Bishop-Bailey D. Peroxisome proliferator-activated receptors in the cardiovascular system. Br J Pharmacol 129: 823-834, 2000
5. Bolli R. Basic and clinical aspects of myocardial stunning. Prog Cardiovasc Dis 40: 477-516, 1998
6. Borchgrevink PC, Bergan AS, Bakoy OE, Jynge P. Magnesium and reperfusion of ischemic rat heart as assessed by 31P-NMR. Am J Physiol 256: H195-H204, 1989
7. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976
8. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137: 354-366, 1996
9. Burton KP, Buja LM, Sen A, Willerson JT, Chien KR. Accumulation of arachidonate in triacylglycerols and unesterified fatty acids during ischemia and reflow in the isolated rat heart. Correlation with the loss of contractile function and the development of calcium overload. Am J Pathol 124: 238-245, 1986
10. Chien KR, Sen A, Reynolds R, Chang A, Kim Y, Gunn MD, Buja LM, Willerson JT. Release of arachidonate from membrane phospholipids in cultured neonatal rat myocardial cells during adenosine triphosphate depletion. Correlation with the progression of cell injury. J Clin Invest 75: 1770-1780, 1985
11. Das DK, Maulik N, Moraru II. Gene expression in acute myocardial stress. Induction by hypoxia, ischemia, reperfusion, hyperthermia and oxidative stress. J Mol Cell Cardiol 27: 181-193, 1995
12. Dormandy TL. Free-radical oxidation and antioxidants. Lancet 1: 647-650, 1978
13. Engelman DT, Chen CZ, Watanabe M, Kulshrestha P, Das DK, Rouson JA, Flack JE III, Deaton DW, Engelman RM. Hypoxic preconditioning enhances functional recovery after prolonged cardioplegic arrest. Ann Thorac Surg 59: 428-432, 1995
14. Khandoudi N, Delerive P, Berrebi-Bertrand I, Buckingham RE, Staels B, Bril A. Rosiglitazone, a peroxisome proliferator- activated receptor-gamma, inhibits the Jun NH2-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury. Diabetes 51: 1507-1514, 2002
15. Kloner RA, Przyklenk K, Whittaker P. Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues. Circulation 80: 1115-1127, 1989
16. Kum-Tatt L, Tan IK. A new colorimetric method for the determination of glutathione in erythrocytes. Clin Chim Acta 53: 153-161, 1974
17. Lawson CS, Coltart DJ, Hearse DJ. The antiarrhythmic action of ischaemic preconditioning in rat hearts does not involve functional Gi proteins. Cardiovasc Res 27: 681-687, 1993
18. Maulik M, Maulik SK, Kumari R. Importance of timing of magnesium administration: a study on the isolated ischemic-reperfused rat heart. Magnes Res 12: 37-42, 1999
19. Maulik N, Watanabe M, Engelman D, Engelman RM, Kagan VE, Kisin E, Tyurin V, Cordis GA, Das DK. Myocardial adaptation to ischemia by oxidative stress induced by endotoxin. Am J Physiol 269: C907-C916, 1995
20. Meerson FZ, Kagan VE, Kozlov Yu P, Belkina LM, Arkhipenko Yu V. The role of lipid peroxidation in pathogenesis of ischemic damage and the antioxidant protection of the heart. Basic Res Cardiol 77: 465-485, 1982
21. Mukherjee R, Jow L, Croston GE, Paterniti JR Jr. Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARgamma2 versus PPARgamma1 and activation with retinoid X receptor agonists and antagonists. J Biol Chem 272: 8071-8076, 1997
22. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358, 1979
23. Schaefer J, Nierhaus KH, Lohff B, Peters T, Schaefer T, Vos R. Mechanisms of autoprotection and the role of stress-proteins in natural defenses, autoprotection, and salutogenesis. Med Hypotheses 51: 153-163, 1998
24. Sevanian A, Hochstein P. Mechanisms and consequences of lipid peroxidation in biological systems. Annu Rev Nutr 5: 365-390, 1985
25. Shimabukuro M, Higa S, Shinzato T, Nagamine F, Komiya I, Takasu N. Cardioprotective effects of troglitazone in streptozotocin-induced diabetic rats. Metabolism 45: 1168-1173, 1996
26. Sidell RJ, Cole MA, Draper NJ, Desrois M, Buckingham RE, Clarke K. Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart. Diabetes 51: 1110-1117, 2002
27. Singal PK, Dhalla AK, Hill M, Thomas TP. Endogenous antioxidant changes in the myocardium in response to acute and chronic stress conditions. Mol Cell Biochem 129: 179-186, 1993
28. Sun JZ, Tang X L, Park SW, Qiu Y, Turrens JF, Bolli R. Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest 97: 562-576, 1996
29. Takano H, Nagai T, Asakawa M, Toyozaki T, Oka T, Komuro I, Saito T, Masuda Y. Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes. Circ Res 87: 596-602, 2000
30. Uchida K, Ogino K, Shimoyama M, Hisatome I, Shigemasa C. Acute hemodynamic effects of insulin-sensitizing agents in isolated perfused rat hearts. Eur J Pharmacol 400: 113-119, 2000
31. Yue Tl TL, Chen J, Bao W, Narayanan PK, Bril A, Jiang W, Lysko PG, Gu JL, Boyce R, Zimmerman DM, Hart TK, Buckingham RE, Ohlstein EH. In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation 104: 2588-2594, 2001